top of page

News
Search


TestAVec and Vidiia accelerating DNA damage testing platform
TestAVec and Vidiia are working together to accelerate DiNARep to commercial testing. DiNARep identifies if patients are able to repair...
Dec 18, 2023


FDA cancer concern over CAR-T gene therapy
Recently, the US Food and Drug Administration (FDA) has expressed that it is investigating cases of blood cancer in CAR-T therapies....
Dec 15, 2023


DNA repair test takes 'hit and miss' out of chemotherapy
Better results for patients on chemotherapy, radiotherapy and gene therapy A personalised test that tells how well chemotherapy,...
Dec 11, 2023


Japanese patent awarded to hInGeTox safety assay
TestAVec's hInGeTox saftey assay has been awarded a patent from Japan. Two of TestAVec's key saftey tests, hInGeTox and DiNARep, have now...
Dec 5, 2023


TestAVec at ESGCT 2023
TestAVec went to the 30th ESGCT Congress, this year held in the beautiful city of Brussels. Robert, Mike and Saqlain attended the...
Oct 31, 2023
bottom of page